Search
for
Sort by
Research 151–180 of 1000+
- Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss.
- Ovarian sex steroid receptors and sex hormones in androgenized rats
- Androgen action on human skin – from basic research to clinical significance
- 5α-reduction of epitestosterone is catalysed by human SRD5A1 and SRD5A2 and increases androgen receptor transactivation
- Androgen regulation of a specific gene in hamster flank organs
- Female androgenetic alopecia with male pattern caused by an androgen-producing tumor
- Nonclassic adrenal hyperplasia
- EP1729 - LBA_ECE_1452 - When PCOS is not PCOS: a diagnostic pitfall of non-classical congenital adrenal hyperplasia
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Diseases of the Canine Prostate Gland
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Congenital Adrenal Hyperplasia
- An Open Randomized Comparative Study of an Oral Contraceptive Containing Ethinyl Estradiol and Cyproterone Acetate with and without the GnRH Analogue Goserelin in the Long-Term Treatment of Hirsutism
- 0980 Tanshinone capsule enhances hair follicle regeneration in a mouse model of androgenetic alopecia via IGF1 and Wnt/β-catenin pathway
- Platelet-rich plasma therapy in the treatment of androgenic alopecia – review
- Referee report. For: Hair greying in castrated mice [version 1; peer review: 1 approved with reservations]
- Effects of Prenatal Treatment with Antiandrogens on Luteinizing Hormone Secretion and Sex Steroid Concentrations in Adult Spotted Hyenas, Crocuta crocuta1
- Male Androgenetic Alopecia - A Review of Current Treatments
- Male Androgenetic Alopecia - A Review of Current Treatments
- Development and validation of a comprehensive in vitro organ model for androgenetic alopecia
- Alopécie frontale fibrosante : à propos de trois cas pédiatriques
- <i>In Vitro</i>and<i>in Vivo</i>Structure-Activity Relationships of Novel Androgen Receptor Ligands with Multiple Substituents in the B-Ring
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Targets to treat androgen excess in polycystic ovary syndrome
- Androgen profile in Chinese women with polycystic ovary syndrome in their reproductive years
- Clinical Utility of GnRH Analogues in Female Androgen Excess: Highlighting Diagnostic and Therapeutic Applications
- Crystallization and preliminary X-ray analysis of the human androgen receptor ligand-binding domain with a coactivator-like peptide and selective androgen receptor modulators